IRS
AZN icon

Invictus RG (Singapore)’s AstraZeneca AZN Stock Holding History

Invictus RG (Singapore)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-940
Closed -$44K – 581
2013
Q2 		$44K Buy
+940
New +$47.9K 0.05% 400

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invictus RG (Singapore)'s AZN Position: Q3 2013 in Review

Invictus RG (Singapore) sold out of AstraZeneca (AZN) in Q3 2013, closing a stake of 940 shares — an estimated $44K sold.

Invictus RG (Singapore) first reported a position in AZN in Q2 2013 and held it in 1 quarter. The position peaked at $44K in Q2 2013. 343 funds tracked by Wall St. Rank hold AZN as of Q3 2013.

  • Invictus RG (Singapore) reported no remaining AstraZeneca position as of Q3 2013 after selling out during the quarter.
  • Invictus RG (Singapore) sold 940 AstraZeneca shares in Q3 2013, an estimated $44K.
  • Invictus RG (Singapore) first reported a position in AstraZeneca in Q2 2013 and held it in 1 quarter.
  • Invictus RG (Singapore)'s AstraZeneca position peaked at $44K in Q2 2013.
  • 343 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2013.

Based on Invictus RG (Singapore)'s 13F filing for Q3 2013, filed 13 Nov 2013.